1. Home
  2. VRDN vs CSGS Comparison

VRDN vs CSGS Comparison

Compare VRDN & CSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • CSGS
  • Stock Information
  • Founded
  • VRDN 2006
  • CSGS 1994
  • Country
  • VRDN United States
  • CSGS United States
  • Employees
  • VRDN N/A
  • CSGS N/A
  • Industry
  • VRDN Medical Specialities
  • CSGS EDP Services
  • Sector
  • VRDN Health Care
  • CSGS Technology
  • Exchange
  • VRDN Nasdaq
  • CSGS Nasdaq
  • Market Cap
  • VRDN 1.6B
  • CSGS 1.7B
  • IPO Year
  • VRDN N/A
  • CSGS 1996
  • Fundamental
  • Price
  • VRDN $12.56
  • CSGS $60.66
  • Analyst Decision
  • VRDN Buy
  • CSGS Buy
  • Analyst Count
  • VRDN 12
  • CSGS 7
  • Target Price
  • VRDN $36.44
  • CSGS $69.29
  • AVG Volume (30 Days)
  • VRDN 718.2K
  • CSGS 325.8K
  • Earning Date
  • VRDN 05-07-2025
  • CSGS 05-07-2025
  • Dividend Yield
  • VRDN N/A
  • CSGS 2.11%
  • EPS Growth
  • VRDN N/A
  • CSGS 37.73
  • EPS
  • VRDN N/A
  • CSGS 3.03
  • Revenue
  • VRDN $302,000.00
  • CSGS $1,197,248,000.00
  • Revenue This Year
  • VRDN N/A
  • CSGS $4.16
  • Revenue Next Year
  • VRDN $17,629.40
  • CSGS $3.37
  • P/E Ratio
  • VRDN N/A
  • CSGS $20.02
  • Revenue Growth
  • VRDN N/A
  • CSGS 2.39
  • 52 Week Low
  • VRDN $11.40
  • CSGS $39.56
  • 52 Week High
  • VRDN $27.20
  • CSGS $67.60
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 28.07
  • CSGS 47.83
  • Support Level
  • VRDN $14.03
  • CSGS $59.06
  • Resistance Level
  • VRDN $15.91
  • CSGS $62.00
  • Average True Range (ATR)
  • VRDN 0.67
  • CSGS 1.44
  • MACD
  • VRDN -0.19
  • CSGS -0.14
  • Stochastic Oscillator
  • VRDN 0.71
  • CSGS 50.30

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.

Share on Social Networks: